MedPath

TEVA-FULVESTRANT INJECTION

TEVA-FULVESTRANT INJECTION

Approved
DIN Number

02460130

Drug Class

Human

Market Date

Jan 15, 2019

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02460130
AIG Number0149744001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BA03 FULVESTRANT
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FULVESTRANTActive
Strength: 50 MG / ML
Monograph: FULVESTRANT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.